SELE and atherosclerosis: TKIs have been shown to promote atherosclerosis by inducing the expression of pro-atherogenic adhesion molecules (CAM) on endothelial cells, including ICAM-1 (CD54), VCAM-1 (CD106) and E-Selectin (CD62E) (Majewska et al., 1997).